AFC Group Holdings Limited (“AFC”) – Final Exercise Date
NZX Limited
Level 1, NZX Centre
11 Cable Street
PO Box 2959
Wellington 6140
New Zealand
Tel +64 4 472 7599
www.nzx.com
Memorandum
To:
Market Participants
From:
NZX Client and Data Services
Date:
13 December 2017
Subject
: AFC Group Holdings Limited (“AFC”) - Final Exercise Date
Message
:
NZX Regulation (“NZXR”) advises that the final exercise date for the AFC warrants (“AFCWA”)
is Sunday, 31 December 2017.
Any AFCWA warrants not exercised by Sunday, 31 December 2017 will lapse and all rights in
regards to them will expire.
The final day of trading in AFCWA will be Wednesday, 27 December 2017 prior to the warrants
being halted and suspended at close of business.
AFCWA will cease to be quoted from market open Wednesday, 3 January 2018.
Please contact NZX Client and Data Services on +64 4 496 2853 or cds@nzx.com with any
queries.
ENDS
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.
Other issuers discussed similar conditions around this time
Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.
- BRM — Barramundi Limited: Barramundi Limited (“BRM”) – Final Exercise Date2017-11-01
“NZX Limited Level 1, NZX Centre 11 Cable Street PO Box 2959 Wellington 6140 New Zealand Tel +64 4 472 7599 www.nzx.com Memorandum To: Market Participants From: NZX Client and Data Services Date: 01 November 2017 Subject : Barramundi Limited (“BRM”) -…”
- AFT — AFT Pharmaceuticals Limited: Waiver from NZX Main Board Listing Rule 5.2.32017-12-19
“NZX Regulation Decision AFT Pharmaceuticals Limited (“AFT”) Waiver from NZX Main Board Listing Rule 5.2.3 20 December 2017 2 of 5 NZX REGULATION DECISION – 20 December 2017 Waiver from Rule 5.2.3 Decision 1. Subject to the conditions set out in paragrap…”
- AFT — AFT Pharmaceuticals Limited: Results for announcement to the market App12017-11-22
“AFT Pharmaceuticals Limited, Level 1, 129 Hurstmere Road, Takapuna, Auckland 0622, New Zealand Incorporated in New Zealand ARBN: ARBN 609 017 969 Additional Information The following is additional information to accompany the Company’s interim report for the six months e…”